Nuclear death receptor trail-r2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells

Gastroenterology

Volumn 146, Issue 1, 2014, Pages 278-290

  Haselmann, Verena ^a   Kurz, Alexandra ^a   Bertsch, Uwe ^a   Hübner, Sebastian ^a   Olempska Müller, Monika ^a   Fritsch, Jürgen ^a   Häsler, Robert ^a   Pickl, Andreas ^a   Fritsche, Hendrik ^a   Annewanter, Franka ^a   Engler, Christine ^a   Fleig, Barbara ^a   Bernt, Alexander ^a   Röder, Christian ^a   Schmidt, Hendrik ^a   Gelhaus, Christoph ^a   Hauser, Charlotte ^a   Egberts, Jan Hendrik ^a   Heneweer, Carola ^a   Rohde, Anna Maria ^b   Böger, Christine ^a   Knippschild, Uwe ^c   Röcken, Christoph ^a   Adam, Dieter ^a   Walczak, Henning ^d   Schütze, Stefan ^a   Janssen, Ottmar ^a   Wulczyn, F Gregory ^b   Wajant, Harald ^e   Kalthoff, Holger ^a   Trauzold, Anna ^a   more..

^a UNIVERSITY OF KIEL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Apoptosis Regulation; MALDI TOF; microRNA Processing; Pancreatic Cancer

Indexed keywords

DEATH RECEPTOR 5; INTERLEUKIN ENHANCER BINDING FACTOR 2; INTERLEUKIN ENHANCER BINDING FACTOR 3; MICRORNA; NUCLEAR PROTEIN; PROTEIN P68; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL NUCLEUS; CELL PROLIFERATION; CELL SURFACE; COLON CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; KIDNEY CANCER; LUNG CANCER; MASS SPECTROMETRY; MICROPROCESSOR; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION; RNA ANALYSIS; RNA PROCESSING; TUMOR CELL; TUMOR GROWTH;

EID: 84890736611     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.10.009     Document Type: Article

References (44)

1. L. Dimberg, C. Anderson, and R. Camidge On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics Oncogene 32 2013 1341 1350
2. P. Secchiero, E. Melloni, and M. Heikinheimo TRAIL regulates normal erythroid maturation through an ERK-dependent pathway Blood 103 2004 517 522
3. D. Siegmund, S. Klose, and D. Zhou Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells Cell Signal 19 2007 1172 1184
4. G. Zauli, S. Sancilio, and A. Cataldi PI-3K/Akt and NF-kappaB/ IkappaBalpha pathways are activated in Jurkat T cells in response to TRAIL treatment J Cell Physiol 202 2005 900 911
5. A. Trauzold, H. Wermann, and A. Arlt CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells Oncogene 20 2001 4258 4269
6. N. Ishimura, H. Isomoto, and S.F. Bronk Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells Am J Physiol Gastrointest Liver Physiol 290 2006 G129 G136
7. A. Trauzold, D. Siegmund, and B. Schniewind TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma Oncogene 25 2006 7434 7439
8. F.J. Hoogwater, M.W. Nijkamp, and N. Smakman Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells Gastroenterology 138 2010 2357 2367
9. K. Azijli, S. Yuvaraj, and M. Peppelenbosch Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells J Cell Sci 125 2012 4651 4661
10. T.M. Ganten, J. Sykora, and R. Koschny Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer J Mol Med 87 2009 995 1007
11. S. Macher-Goeppinger, S. Aulmann, and K.E. Tagscherer Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer Clin Cancer Res 15 2009 650 659
12. E. Oikonomou, V. Kosmidou, and A. Katseli TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors Int J Cancer 125 2009 2127 2135
13. A.D. Sanlioglu, A.F. Korcum, and E. Pestereli TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma Int J Radiat Oncol Biol Phys 69 2007 716 723
14. D.C. Spierings, E.G. de Vries, and W. Timens Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors Clin Cancer Res 9 2003 3397 3405
15. X. Bai, J.L. Williams, and S.L. Greenwood A placental protective role for trophoblast-derived TNF-related apoptosis-inducing ligand (TRAIL) Placenta 30 2009 855 860
16. Y. Kojima, M. Nakayama, and T. Nishina Importin {beta}1-mediated nuclear localization of death receptor 5 (DR5) limits DR5/TNF-related apoptosis inducing ligand (TRAIL)-induced cell death of human tumor cells J Biol Chem 286 2011 43383 43393
17. Y. Niu, Y. Li, and J. Zang Death receptor 5 and neuroproliferation Cell Mol Neurobiol 32 2012 255 265
18. B. Boyerinas, S.M. Park, and A. Hau The role of let-7 in cell differentiation and cancer Endocr Relat Cancer 17 2010 F19 F36
19. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
20. J. Lemke, A. Noack, and D. Adam TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5 J Mol Med 88 2010 729 740
21. M. Tsutsui, H. Hasegawa, and K. Adachi Establishment of cells to monitor Microprocessor through fusion genes of microRNA and GFP Biochem Biophys Res Commun 372 2008 856 861
22. J.H. Egberts, V. Cloosters, and A. Noack Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis Cancer Res 68 2008 1443 1450
23. R.C. Humphreys, and W. Halpern Trail receptors: targets for cancer therapy Adv Exp Med Biol 615 2008 127 158
24. T. Fukuda, K. Yamagata, and S. Fujiyama DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs Nat Cell Biol 9 2007 604 611
25. R.I. Gregory, K.P. Yan, and G. Amuthan The microprocessor complex mediates the genesis of microRNAs Nature 432 2004 235 240
26. D.W. Salzman, J. Shubert-Coleman, and H. Furneaux P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression J Biol Chem 282 2007 32773 32779
27. S. Sakamoto, K. Aoki, and T. Higuchi The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway Mol Cell Biol 29 2009 3754 3769
28. G. Michlewski, and J.F. Caceres Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis Nat Struct Mol Biol 17 2010 1011 1018
29. Y.S. Lee, and A. Dutta The tumor suppressor microRNA let-7 represses the HMGA2 oncogene Genes Dev 21 2007 1025 1030
30. S.M. Park, S. Shell, and A.R. Radjabi Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2 Cell Cycle 6 2007 2585 2590
31. A. Rybak, H. Fuchs, and L. Smirnova A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment Nat Cell Biol 10 2008 987 993
32. I. Cleynen, and W.J. Van de Ven The HMGA proteins: a myriad of functions (review) Int J Oncol 32 2008 289 305
33. D. Iliopoulos, H.A. Hirsch, and K. Struhl An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation Cell 139 2009 693 706
34. B. Boyerinas, S.M. Park, and N. Shomron Identification of let-7-regulated oncofetal genes Cancer Res 68 2008 2587 2591
35. E.R. McDonald, P.C. Chui, and P.F. Martelli Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling J Biol Chem 276 2001 14939 14945
36. L. Lehnert, M.M. Lerch, and Y. Hirai Autocrine stimulation of human pancreatic duct-like development by soluble isoforms of epimorphin in vitro J Cell Biol 152 2001 911 922
37. B.J. Winterhoff, A. Arlt, and A. Duttmann Characterisation of FAP-1 expression and CD95 mediated apoptosis in the A818-6 pancreatic adenocarcinoma differentiation system Differentiation 83 2012 148 157
38. N.V. Rajeshkumar, Z.A. Rasheed, and E. Garcia-Garcia A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model Mol Cancer Ther 9 2010 2582 2592
39. K. Leithner, E. Stacher, and R. Wurm Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy Lung Cancer 65 2009 98 104
40. D. Barh, R. Malhotra, and B. Ravi MicroRNA let-7: an emerging next-generation cancer therapeutic Curr Oncol 17 2010 70 80
41. S.R. Viswanathan, J.T. Powers, and W. Einhorn Lin28 promotes transformation and is associated with advanced human malignancies Nat Genet 41 2009 843 848
42. Y.N. Wang, H. Yamaguchi, and J.M. Hsu Nuclear trafficking of the epidermal growth factor receptor family membrane proteins Oncogene 29 2010 3997 4006
43. L.Y. Li, H. Chen, and Y.H. Hsieh Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes Cancer Res 71 2011 4269 4279
44. H.J. Zhou, L.V. Pham, and A.T. Tamayo Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma Blood 110 2007 2121 2127